These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 4584450

  • 21. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 22. Measles and rubella immunization. Statement of the Committe on Infectious Diseases, American Academy of Pediatrics.
    Postgrad Med; 1977 Jan; 61(1):269-72. PubMed ID: 834685
    [No Abstract] [Full Text] [Related]

  • 23. Control of measles and rubella through use of attenuated vaccines.
    Meyer HM, Hopps HE, Parkman PD, Ennis FA.
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):128-35. PubMed ID: 685885
    [Abstract] [Full Text] [Related]

  • 24. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M.
    Vaccine; 2007 Apr 20; 25(16):3105-10. PubMed ID: 17306425
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS.
    Dev Biol Stand; 1976 Apr 20; 33():237-40. PubMed ID: 782973
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M, Kato T, Inoue E, Sago H, Yamaguchi K.
    Vaccine; 2016 Feb 24; 34(9):1208-14. PubMed ID: 26801065
    [Abstract] [Full Text] [Related]

  • 30. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J.
    CMAJ; 1996 May 15; 154(10):1567-8. PubMed ID: 8625011
    [Abstract] [Full Text] [Related]

  • 31. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Feb 25; 54(7):175-8. PubMed ID: 15729220
    [Abstract] [Full Text] [Related]

  • 32. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M, Cajal N, Cernescu C, Sorodoc Y, Aderca I, Tigăeru N, Suciu D, Manu S, Ferra A, Biberimoroianu S, Dobrescu A, Lucian M.
    Rev Roum Virol (1972); 1973 Feb 25; 10(1):8-17. PubMed ID: 4709858
    [No Abstract] [Full Text] [Related]

  • 33. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E, Jonville-Béra AP, Galy-Eyraud C, Hessel L.
    Therapie; 1996 Feb 25; 51(6):677-80. PubMed ID: 9164004
    [Abstract] [Full Text] [Related]

  • 34. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [Abstract] [Full Text] [Related]

  • 35. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N, Cepleanu M, Cernesc C, Sorodoc Y, Tigăeru N, Biberi-Moroianu S, Cuciu D, Brebenel G, Vucu E, Petrescu A.
    Stud Cercet Virusol; 1973 May 15; 24(5):349-56. PubMed ID: 4747453
    [No Abstract] [Full Text] [Related]

  • 36. [Practical application of measles and rubella vaccinations 12 years later].
    Lambert R, Chenu M.
    Ann Pediatr (Paris); 1984 Jun 15; 31(6):493-6. PubMed ID: 6465802
    [No Abstract] [Full Text] [Related]

  • 37. Surveillance of rubella since the MR vaccination campaign.
    Commun Dis Rep CDR Wkly; 1995 Apr 28; 5(17):81. PubMed ID: 7749459
    [No Abstract] [Full Text] [Related]

  • 38. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S, Naficy K.
    Am J Dis Child; 1969 Aug 28; 118(2):209-12. PubMed ID: 5794816
    [No Abstract] [Full Text] [Related]

  • 39. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
    Nasibov MN, Yakovleva NV, Smorodintsev AA.
    Prog Immunobiol Stand; 1970 Aug 28; 4():676-82. PubMed ID: 5482205
    [No Abstract] [Full Text] [Related]

  • 40. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance].
    Ziemer B, Blank K, Hennig R.
    Gesundheitswesen; 1998 May 28; 60(5):297-300. PubMed ID: 9676011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.